CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,495,000 | -24.5% | 170,000 | 0.0% | 4.10% | -7.1% |
| Q1 2022 | $5,952,000 | -65.6% | 170,000 | -74.8% | 4.41% | +2.6% |
| Q2 2021 | $17,311,000 | -27.1% | 675,670 | -60.9% | 4.30% | -5.5% |
| Q1 2021 | $23,734,000 | -19.0% | 1,728,590 | -2.2% | 4.55% | -9.4% |
| Q4 2020 | $29,304,000 | – | 1,767,440 | – | 5.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |